Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull
In particular, shareholders approved the election of all director nominees, the re-approval of Ernst & Young LLP as the Company's auditors and approving the unallocated shares, rights and other entitlements under the Company's share purchase plan.
Source: pressreleasepoint.com
